Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 260

1.

Simu-dependent clearance of dying cells regulates macrophage function and inflammation resolution.

Roddie HG, Armitage EL, Coates JA, Johnston SA, Evans IR.

PLoS Biol. 2019 May 14;17(5):e2006741. doi: 10.1371/journal.pbio.2006741. eCollection 2019 May.

2.

15-keto-prostaglandin E2 activates host peroxisome proliferator-activated receptor gamma (PPAR-γ) to promote Cryptococcus neoformans growth during infection.

Evans RJ, Pline K, Loynes CA, Needs S, Aldrovandi M, Tiefenbach J, Bielska E, Rubino RE, Nicol CJ, May RC, Krause HM, O'Donnell VB, Renshaw SA, Johnston SA.

PLoS Pathog. 2019 Mar 28;15(3):e1007597. doi: 10.1371/journal.ppat.1007597. eCollection 2019 Mar.

3.

Bayesian Polytrees With Learned Deep Features for Multi-Class Cell Segmentation.

Fehri H, Gooya A, Lu Y, Meijering E, Johnston SA, Frangi AF.

IEEE Trans Image Process. 2019 Jul;28(7):3246-3260. doi: 10.1109/TIP.2019.2895455. Epub 2019 Jan 25.

4.

Inhibition of Classical and Alternative Modes of Respiration in Candida albicans Leads to Cell Wall Remodeling and Increased Macrophage Recognition.

Duvenage L, Walker LA, Bojarczuk A, Johnston SA, MacCallum DM, Munro CA, Gourlay CW.

MBio. 2019 Jan 29;10(1). pii: e02535-18. doi: 10.1128/mBio.02535-18.

5.

A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.

Probert M, Zhou X, Goodall M, Johnston SA, Bielska E, Ballou ER, May RC.

Infect Immun. 2019 Mar 25;87(4). pii: e00731-18. doi: 10.1128/IAI.00731-18. Print 2019 Apr.

6.

Using Frameshift Peptide Arrays for Cancer Neo-Antigens Screening.

Zhang J, Shen L, Johnston SA.

Sci Rep. 2018 Nov 26;8(1):17366. doi: 10.1038/s41598-018-35673-0.

7.

Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Günther OP, Gardy JL, Stafford P, Fluge Ø, Mella O, Tang P, Miller RR, Parker SM, Johnston SA, Patrick DM.

Mol Neurobiol. 2019 Jun;56(6):4249-4257. doi: 10.1007/s12035-018-1354-8. Epub 2018 Oct 8.

8.

Cryptococcus neoformans Escape From Dictyostelium Amoeba by Both WASH-Mediated Constitutive Exocytosis and Vomocytosis.

Watkins RA, Andrews A, Wynn C, Barisch C, King JS, Johnston SA.

Front Cell Infect Microbiol. 2018 Apr 9;8:108. doi: 10.3389/fcimb.2018.00108. eCollection 2018.

9.

Generation of High-Specificity Antibodies against Membrane Proteins Using DNA-Gold Micronanoplexes for Gene Gun Immunization.

Hansen DT, Craciunescu FM, Fromme P, Johnston SA, Sykes KF.

Curr Protoc Protein Sci. 2018 Feb 21;91:29.20.1-29.20.22. doi: 10.1002/cpps.50.

10.

A transgenic zebrafish model for the in vivo study of the blood and choroid plexus brain barriers using claudin 5.

van Leeuwen LM, Evans RJ, Jim KK, Verboom T, Fang X, Bojarczuk A, Malicki J, Johnston SA, van der Sar AM.

Biol Open. 2018 Feb 2;7(2). pii: bio030494. doi: 10.1242/bio.030494.

11.

Non-natural amino acid peptide microarrays to discover Ebola virus glycoprotein ligands.

Rabinowitz JA, Lainson JC, Johnston SA, Diehnelt CW.

Chem Commun (Camb). 2018 Feb 6;54(12):1417-1420. doi: 10.1039/c7cc08242h.

PMID:
29297911
12.

Entropy is a Simple Measure of the Antibody Profile and is an Indicator of Health Status: A Proof of Concept.

Wang L, Whittemore K, Johnston SA, Stafford P.

Sci Rep. 2017 Dec 22;7(1):18060. doi: 10.1038/s41598-017-18469-6.

13.

Peptide Sequencing Directly on Solid Surfaces Using MALDI Mass Spectrometry.

Zhao ZG, Cordovez LA, Johnston SA, Woodbury N.

Sci Rep. 2017 Dec 19;7(1):17811. doi: 10.1038/s41598-017-18105-3.

14.

A Simple Platform for the Rapid Development of Antimicrobials.

Johnston SA, Domenyuk V, Gupta N, Batista MT, Lainson JC, Zhao ZG, Lusk JF, Loskutov A, Cichacz Z, Stafford P, Legutki JB, Diehnelt CW.

Sci Rep. 2017 Dec 14;7(1):17610. doi: 10.1038/s41598-017-17941-7.

15.

The cause and effect of Cryptococcus interactions with the host.

Ballou ER, Johnston SA.

Curr Opin Microbiol. 2017 Dec;40:88-94. doi: 10.1016/j.mib.2017.10.012. Epub 2017 Nov 15. Review.

16.

LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1.

Batista MT, Ferreira EL, Pereira GS, Stafford P, Maeda DLNF, Rodrigues JF, Brady LJ, Johnston SA, Ferreira LCS, Ferreira RCC.

Vaccine. 2017 Dec 19;35(52):7273-7282. doi: 10.1016/j.vaccine.2017.11.007. Epub 2017 Nov 13.

PMID:
29146379
17.

Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein.

Maeda DLNF, Batista MT, Pereira LR, de Jesus Cintra M, Amorim JH, Mathias-Santos C, Pereira SA, Boscardin SB, Silva SDR, Faquim-Mauro EL, Silveira VB, Oliveira DBL, Johnston SA, Ferreira LCS, Rodrigues JF.

Front Immunol. 2017 Sep 25;8:1175. doi: 10.3389/fimmu.2017.01175. eCollection 2017.

18.

Nutritional Requirements and Their Importance for Virulence of Pathogenic Cryptococcus Species.

Watkins RA, King JS, Johnston SA.

Microorganisms. 2017 Sep 30;5(4). pii: E65. doi: 10.3390/microorganisms5040065. Review.

19.

Vomocytosis of live pathogens from macrophages is regulated by the atypical MAP kinase ERK5.

Gilbert AS, Seoane PI, Sephton-Clark P, Bojarczuk A, Hotham R, Giurisato E, Sarhan AR, Hillen A, Velde GV, Gray NS, Alessi DR, Cunningham DL, Tournier C, Johnston SA, May RC.

Sci Adv. 2017 Aug 16;3(8):e1700898. doi: 10.1126/sciadv.1700898. eCollection 2017 Aug.

20.

Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA.

Lainson JC, Daly SM, Triplett K, Johnston SA, Hall PR, Diehnelt CW.

ACS Med Chem Lett. 2017 Jul 7;8(8):853-857. doi: 10.1021/acsmedchemlett.7b00200. eCollection 2017 Aug 10.

21.

Experiences of rosacea and its treatment: an interpretative phenomenological analysis.

Johnston SA, Krasuska M, Millings A, Lavda AC, Thompson AR.

Br J Dermatol. 2018 Jan;178(1):154-160. doi: 10.1111/bjd.15780. Epub 2017 Dec 5.

22.

Cross-Reactive Synbody Affinity Ligands for Capturing Diverse Noroviruses.

Gupta N, Lainson JC, Belcher PE, Shen L, Mason HS, Johnston SA, Diehnelt CW.

Anal Chem. 2017 Jul 5;89(13):7174-7181. doi: 10.1021/acs.analchem.7b01337. Epub 2017 Jun 22.

PMID:
28640636
23.

Microevolutionary traits and comparative population genomics of the emerging pathogenic fungus Cryptococcus gattii.

Farrer RA, Voelz K, Henk DA, Johnston SA, Fisher MC, May RC, Cuomo CA.

Philos Trans R Soc Lond B Biol Sci. 2016 Dec 5;371(1709). pii: 20160021. doi: 10.1098/rstb.2016.0021.

24.

Humoral Immunity Profiling of Subjects with Myalgic Encephalomyelitis Using a Random Peptide Microarray Differentiates Cases from Controls with High Specificity and Sensitivity.

Singh S, Stafford P, Schlauch KA, Tillett RR, Gollery M, Johnston SA, Khaiboullina SF, De Meirleir KL, Rawat S, Mijatovic T, Subramanian K, Palotás A, Lombardi VC.

Mol Neurobiol. 2018 Jan;55(1):633-641. doi: 10.1007/s12035-016-0334-0. Epub 2016 Dec 15.

25.

Diagnosing and treating depression in epilepsy.

Elger CE, Johnston SA, Hoppe C.

Seizure. 2017 Jan;44:184-193. doi: 10.1016/j.seizure.2016.10.018. Epub 2016 Oct 31. Review.

26.

Using Flow Cytometry to Analyze Cryptococcus Infection of Macrophages.

Evans RJ, Voelz K, Johnston SA, May RC.

Methods Mol Biol. 2017;1519:349-357.

27.

Interaction of Serum Antibodies from Breast Cancer Patients with Synthetic Peptides.

Podlesnykh SV, Kolosova EA, Shcherbakov DN, Shaidurov AA, Anisimov DS, Ryazanov MA, Johnston SA, Shoikhet YN, Petrova VD, Lazarev AF, Chapoval AI.

Bull Exp Biol Med. 2016 Oct;161(6):816-820. Epub 2016 Oct 26.

PMID:
27783295
28.

Whole-Virus Screening to Develop Synbodies for the Influenza Virus.

Gupta N, Lainson J, Domenyuk V, Zhao ZG, Johnston SA, Diehnelt CW.

Bioconjug Chem. 2016 Oct 19;27(10):2505-2512. Epub 2016 Sep 23.

PMID:
27658460
29.

CD4-Transgenic Zebrafish Reveal Tissue-Resident Th2- and Regulatory T Cell-like Populations and Diverse Mononuclear Phagocytes.

Dee CT, Nagaraju RT, Athanasiadis EI, Gray C, Fernandez Del Ama L, Johnston SA, Secombes CJ, Cvejic A, Hurlstone AF.

J Immunol. 2016 Nov 1;197(9):3520-3530. Epub 2016 Sep 30.

30.

WASH drives early recycling from macropinosomes and phagosomes to maintain surface phagocytic receptors.

Buckley CM, Gopaldass N, Bosmani C, Johnston SA, Soldati T, Insall RH, King JS.

Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):E5906-E5915. Epub 2016 Sep 19.

31.

A General Method to Discover Epitopes from Sera.

Whittemore K, Johnston SA, Sykes K, Shen L.

PLoS One. 2016 Jun 14;11(6):e0157462. doi: 10.1371/journal.pone.0157462. eCollection 2016.

32.

General Assessment of Humoral Activity in Healthy Humans.

Stafford P, Wrapp D, Johnston SA.

Mol Cell Proteomics. 2016 May;15(5):1610-21. doi: 10.1074/mcp.M115.054601. Epub 2016 Feb 22.

33.

Cryptococcus neoformans Intracellular Proliferation and Capsule Size Determines Early Macrophage Control of Infection.

Bojarczuk A, Miller KA, Hotham R, Lewis A, Ogryzko NV, Kamuyango AA, Frost H, Gibson RH, Stillman E, May RC, Renshaw SA, Johnston SA.

Sci Rep. 2016 Feb 18;6:21489. doi: 10.1038/srep21489.

35.

Conjugation Approach To Produce a Staphylococcus aureus Synbody with Activity in Serum.

Lainson JC, Fuenmayor MF, Johnston SA, Diehnelt CW.

Bioconjug Chem. 2015 Oct 21;26(10):2125-32. doi: 10.1021/acs.bioconjchem.5b00420. Epub 2015 Sep 14.

PMID:
26365100
36.

Inability to sustain intraphagolysosomal killing of Staphylococcus aureus predisposes to bacterial persistence in macrophages.

Jubrail J, Morris P, Bewley MA, Stoneham S, Johnston SA, Foster SJ, Peden AA, Read RC, Marriott HM, Dockrell DH.

Cell Microbiol. 2016 Jan;18(1):80-96. doi: 10.1111/cmi.12485. Epub 2015 Sep 2.

37.

Immunosignature: Serum Antibody Profiling for Cancer Diagnostics.

Chapoval AI, Legutki JB, Stafford P, Trebukhov AV, Johnston SA, Shoikhet YN, Lazarev AF.

Asian Pac J Cancer Prev. 2015;16(12):4833-7. Review.

38.

Immunity to Cryptococcus neoformans and C. gattii during cryptococcosis.

Gibson JF, Johnston SA.

Fungal Genet Biol. 2015 May;78:76-86. doi: 10.1016/j.fgb.2014.11.006. Epub 2014 Dec 12. Review.

39.

Peptide based diagnostics: are random-sequence peptides more useful than tiling proteome sequences?

Navalkar KA, Johnston SA, Stafford P.

J Immunol Methods. 2015 Feb;417:10-21. doi: 10.1016/j.jim.2014.12.002. Epub 2014 Dec 11.

PMID:
25497701
40.

Epitope identification from fixed-complexity random-sequence peptide microarrays.

Richer J, Johnston SA, Stafford P.

Mol Cell Proteomics. 2015 Jan;14(1):136-47. doi: 10.1074/mcp.M114.043513. Epub 2014 Nov 3.

41.

'Division of labour' in response to host oxidative burst drives a fatal Cryptococcus gattii outbreak.

Voelz K, Johnston SA, Smith LM, Hall RA, Idnurm A, May RC.

Nat Commun. 2014 Oct 17;5:5194. doi: 10.1038/ncomms6194.

42.

The immunosignature of canine lymphoma: characterization and diagnostic application.

Johnston SA, Thamm DH, Legutki JB.

BMC Cancer. 2014 Sep 8;14:657. doi: 10.1186/1471-2407-14-657.

43.

Scalable high-density peptide arrays for comprehensive health monitoring.

Legutki JB, Zhao ZG, Greving M, Woodbury N, Johnston SA, Stafford P.

Nat Commun. 2014 Sep 3;5:4785. doi: 10.1038/ncomms5785.

PMID:
25183057
44.

Immunosignature system for diagnosis of cancer.

Stafford P, Cichacz Z, Woodbury NW, Johnston SA.

Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3072-80. doi: 10.1073/pnas.1409432111. Epub 2014 Jul 14.

45.

Application of immunosignatures for diagnosis of valley fever.

Navalkar KA, Johnston SA, Woodbury N, Galgiani JN, Magee DM, Chicacz Z, Stafford P.

Clin Vaccine Immunol. 2014 Aug;21(8):1169-77. doi: 10.1128/CVI.00228-14. Epub 2014 Jun 25.

46.

Efficient phagocytosis and laccase activity affect the outcome of HIV-associated cryptococcosis.

Sabiiti W, Robertson E, Beale MA, Johnston SA, Brouwer AE, Loyse A, Jarvis JN, Gilbert AS, Fisher MC, Harrison TS, May RC, Bicanic T.

J Clin Invest. 2014 May;124(5):2000-8. doi: 10.1172/JCI72950. Epub 2014 Apr 17.

47.

Could immunosignatures technology enable the development of a preventative cancer vaccine?

Shen L, Hansen DT, Johnston SA, Legutki JB.

Expert Rev Vaccines. 2014 May;13(5):577-9. doi: 10.1586/14760584.2014.897616. Epub 2014 Mar 18.

PMID:
24641768
48.

Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Almagro JC, Gilliland GL, Breden F, Scott JK, Sok D, Pauthner M, Reichert JM, Helguera G, Andrabi R, Mabry R, Bléry M, Voss JE, Laurén J, Abuqayyas L, Barghorn S, Ben-Jacob E, Crowe JE Jr, Huston JS, Johnston SA, Krauland E, Lund-Johansen F, Marasco WA, Parren PW, Xu KY.

MAbs. 2014 May-Jun;6(3):577-618. doi: 10.4161/mabs.28421. Epub 2014 Mar 3.

49.

A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies.

Bruce JY, Kolesar JM, Hammers H, Stein MN, Carmichael L, Eickhoff J, Johnston SA, Binger KA, Heideman JL, Perlman SB, Jeraj R, Liu G.

Cancer Chemother Pharmacol. 2014 Mar;73(3):485-93. doi: 10.1007/s00280-013-2373-9. Epub 2014 Jan 12.

50.

Immunosignatures can predict vaccine efficacy.

Legutki JB, Johnston SA.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18614-9. doi: 10.1073/pnas.1309390110. Epub 2013 Oct 28.

Supplemental Content

Loading ...
Support Center